These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1167 related articles for article (PubMed ID: 26868660)

  • 21. Pharmacotherapy of obesity: Available medications and drugs under investigation.
    Pilitsi E; Farr OM; Polyzos SA; Perakakis N; Nolen-Doerr E; Papathanasiou AE; Mantzoros CS
    Metabolism; 2019 Mar; 92():170-192. PubMed ID: 30391259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of new antiobesity drugs.
    Hainer V
    Expert Opin Pharmacother; 2014 Oct; 15(14):1975-8. PubMed ID: 25100293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy comparison of medications approved for chronic weight management.
    Kumar RB; Aronne LJ
    Obesity (Silver Spring); 2015 Apr; 23 Suppl 1():S4-7. PubMed ID: 25900871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity in women.
    Ryan DH; Braverman-Panza J
    J Fam Pract; 2014 Feb; 63(2 Suppl):S15-20. PubMed ID: 24527479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent concepts of pharmacotherapy and bariatric surgery for childhood obesity: an overview.
    Gogakos A; Tzotzas TC; Krassas GE
    Pediatr Endocrinol Rev; 2009 Dec; 7(2):3-14. PubMed ID: 20118889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity consults--comprehensive obesity management in 2013: understanding the shifting paradigm.
    Kushner RF; Apovian CM; Fujioka K
    Obesity (Silver Spring); 2013 Nov; 21 Suppl 2():S3-13; quiz S14-5. PubMed ID: 24259347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on obesity pharmacotherapy.
    Bray GA; Ryan DH
    Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?
    Miras AD; le Roux CW
    Int J Obes (Lond); 2014 Mar; 38(3):325-33. PubMed ID: 24213310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management.
    Fujioka K; Braverman-Panza J
    J Fam Pract; 2016 Jul; 65(7 Suppl):S16-23. PubMed ID: 27565106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of non-responders following bariatric surgery.
    Vinciguerra F; Romeo LM; Frittitta L; Baratta R
    Minerva Endocrinol (Torino); 2024 Jun; 49(2):196-204. PubMed ID: 33792233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight loss medications--where do they fit in?
    Dixon JB
    Aust Fam Physician; 2006 Aug; 35(8):576-9. PubMed ID: 16894428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for Obesity.
    Saunders KH; Shukla AP; Igel LI; Kumar RB; Aronne LJ
    Endocrinol Metab Clin North Am; 2016 Sep; 45(3):521-38. PubMed ID: 27519128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity: Pathophysiology and Management.
    Gadde KM; Martin CK; Berthoud HR; Heymsfield SB
    J Am Coll Cardiol; 2018 Jan; 71(1):69-84. PubMed ID: 29301630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
    Verpeut JL; Bello NT
    Expert Opin Drug Saf; 2014 Jun; 13(6):831-41. PubMed ID: 24766397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for obesity in individuals with type 2 diabetes.
    Chukir T; Shukla AP; Saunders KH; Aronne LJ
    Expert Opin Pharmacother; 2018 Feb; 19(3):223-231. PubMed ID: 29376439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Antiobesity Treatment and Weight-Inducing Antihyperglycemic Agents Among Patients With Type 2 Diabetes in the United States.
    Levin A; Kaur N; Mainoo NK; Perez A
    Clin Ther; 2022 Mar; 44(3):e35-e44. PubMed ID: 35105470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Past, Present, and Future of Pharmacologic Therapy in Obesity.
    Rodríguez JE; Campbell KM
    Prim Care; 2016 Mar; 43(1):61-7, viii. PubMed ID: 26896200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic Approaches to Weight Management: Recent Gains and Shortfalls in Combating Obesity.
    Saunders KH; Kumar RB; Igel LI; Aronne LJ
    Curr Atheroscler Rep; 2016 Jul; 18(7):36. PubMed ID: 27181165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHALLENGES AND NEW DIRECTIONS IN OBESITY MANAGEMENT: LIFESTYLE MODIFICATION PROGRAMMES, PHARMACOTHERAPY AND BARIATRIC SURGERY.
    El Ghoch M; Fakhoury R
    J Popul Ther Clin Pharmacol; 2019 May; 26(2):e1-e4. PubMed ID: 31577079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Past, present and future of pharmacotherapy for obesity.
    Benaiges D; Pedro-Botet J; Flores-Le Roux JA; Climent E; Goday A
    Clin Investig Arterioscler; 2017; 29(6):256-264. PubMed ID: 28935287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.